Skip to content

Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis

Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis: PATIENT-UC

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02569333
Acronym
PATIENT-UC
Enrollment
91
Registered
2015-10-06
Start date
2016-01-31
Completion date
2020-01-31
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colitis, Colitis, Ulcerative, Inflammatory Bowel Diseases, Intestinal Disease

Keywords

ulcerative colitis, inflammatory bowel disease, education, patient-reported outcomes

Brief summary

Hospitalized patients with ulcerative colitis (UC) are at increased risk for a variety of complications such as infections, venous thrombosis, and surgery. The literature has revealed significant variation in the quality of care to hospitalized UC patients. As a result, guidelines for the management of these patients have been developed. However, the update of guidelines are variable. Admission to hospital can also have significant impact on quality of life due to interruptions in life commitments and lost sense of control of disease. Maintaining a sense of self-control of disease and active participation in care has been shown to be valuable among individuals with chronic diseases. The investigators propose the development of a multi-site, patient centred initiative aimed at improving clinical and patient-centered outcomes through an educational iPad based tool for patients admitted to hospital with ulcerative colitis.

Detailed description

Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition with significant morbidity in the form of hospitalizations, surgery, and reductions in quality of life. Most patients with IBD are managed in an ambulatory, outpatient setting. However, to optimally manage severe disease activity, hospitalization may be required. Hospitalized patients are at increased risk for a variety of complications such as infections, venous thrombosis, and surgery. The literature has revealed significant variation in care and disease outcomes among hospitalized IBD patients. The heterogeneous nature of IBD severity, location, and phenotype as well as limited evidence to guide some therapeutic domains make standardization of IBD care delivery difficult. However, hospitalized patients with ulcerative colitis (UC) represent a more homogenous group that may be most amendable to quality improvement initiatives aimed at reducing variation, a known surrogate marker of poor performance. The Canadian Association of Gastroenterology has developed guidelines for hospitalized UC patients. It is well established, however, that update of guidelines are variable. Admission to hospital can also have significant impact on quality of life due to interruptions in life commitments and lost sense of control of disease. Maintaining a sense of self-control of disease and active participation in care has been shown to be valuable among individuals with chronic diseases such as IBD. The investigators proposed the development of a multi-site, patient centered initiative aimed at improving clinically relevant and patient-centered outcomes through a multi-faceted educational tool for patients admitted to hospital with ulcerative colitis. Participating sites will be randomized to usual care versus administering the educational tool to patients which outlines what to expect during their hospital stay and reviews the current guidelines for hospitalized ulcerative colitis management.

Interventions

OTHEREducational video

iPad with educational video highlighting current guidelines for the management of hospitalized patients with ulcerative colitis.

Sponsors

University of British Columbia
CollaboratorOTHER
University of Calgary
CollaboratorOTHER
University of Manitoba
CollaboratorOTHER
University of Ottawa
CollaboratorOTHER
McGill University
CollaboratorOTHER
University of Alberta
CollaboratorOTHER
Dalhousie University
CollaboratorOTHER
Mount Sinai Hospital, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of ulcerative colitis * able to provide informed consent * admission to hospital with flare of underlying ulcerative colitis

Exclusion criteria

* Crohn's disease * inability to provide informed consent * readmission during study period (intervention would only be used on the initial admission during the study period)

Design outcomes

Primary

MeasureTime frame
Overall length of stay1 year
Percentage of patients undergoing colectomy1 year

Other

MeasureTime frame
Proportion of patients receiving VTE prophylaxis1 year
Trust in physician as measured by TIPS6 months
Proportion of patient undergoing testing of C difficile within 48 hours of admission1 year
Anxiety and Depression as measured by HADS.6 months
Adherence to Medication as measured by Morisky scale6 months
Patient Satisfaction as measured by CACHE6 months
Time from initiation of IV steroids to salvage therapy or surgery.1 year

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026